A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
City of Hope Medical Center
City of Hope Medical Center